Role of sodium nitroprusside in regulating retinal ganglion cell damage through mitochondrial transcription factor A

Xiao Liu1, Luosheng Tang1, Baihua Chen1

  • 1Department of Ophthalmology, The Second Xiangya hospital of Central South University, No. 139, Ren Min Zhong Road, Changsha 410008, China.

Neuroscience Letters
|October 30, 2016
PubMed

Insights

Nitric oxide (NO) damages mitochondrial DNA and affects retinal ganglion cell (RGC) viability. Mitochondrial transcription factor A (TFAM) plays a key role in regulating these NO-induced effects.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Nitric oxide (NO) is implicated in cellular toxicity, apoptosis, and genotoxicity, particularly damaging mitochondrial DNA (mtDNA).
  • Sodium Nitroprusside (SNP) is a nitric oxide donor used to study NO-related cellular effects.
  • Mitochondrial transcription factor A (TFAM) is crucial for mtDNA maintenance and mitochondrial homeostasis.

Purpose of the Study:

  • To investigate the role of TFAM in regulating retinal ganglion cell (RGC) viability and mtDNA copy numbers under Sodium Nitroprusside (SNP) treatment.
  • To elucidate the mechanism by which TFAM influences SNP-induced cellular changes, focusing on apoptosis-related proteins.

Main Methods:

  • Treatment of RGCs with varying doses of SNP.
  • Assessment of RGC viability and mtDNA copy numbers.
  • Analysis of TFAM expression levels.
  • Manipulation of TFAM expression (overexpression and inhibition).
  • Measurement of apoptosis-related proteins (Bcl-2, Bax) in mitochondria.

Main Results:

  • Low-dose SNP up-regulated TFAM expression, while high-dose SNP down-regulated it.
  • TFAM overexpression mitigated SNP's effects on RGC viability and mtDNA copy number.
  • TFAM inhibition exacerbated SNP's effects on RGC viability and mtDNA copy number.
  • SNP treatment altered the expression of mitochondrial apoptosis regulators Bcl-2 and Bax.

Conclusions:

  • TFAM modulates SNP-induced alterations in RGC viability and mtDNA copy number.
  • The mechanism involves the mitochondria-dependent pathway, mediated by Bcl-2 and Bax subfamily proteins.
  • TFAM is a critical factor in the cellular response to nitric oxide-induced stress.

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K